International Journal of Rheumatic Diseases · 2020 · 11 citations · 22 references
Life SciencesGeneticsImmunologyClinical ImmunologyHuman GeneticsImmunogeneticsAutoimmune DiseasesDisease Susceptibility LociHistocompatibilityHla TypingHuman Leukocyte Antigen SystemMajor Histocompatibility ComplexAllele FrequencyHla Allele Frequency DistributionHla Allele PolymorphismHla AllelesHla Genotype AssociationsHla Risk AllelesHuman Leukocyte Antigen-b51Mhc Polymorphism
AIMS: To investigate susceptible human leukocyte antigen (HLA) alleles and their associations with clinical features in Thai patients with Behçet's disease (BD). METHOD: Eighteen HLA-A and 36 HLA-B alleles were determined in 42 Thai BD patients and 99 healthy controls (HCs) by reverse line blot assay, and reconfirmed by MICRO SSP assay. RESULTS: The BD patients had significantly higher allele frequency (AF) of HLA-B*51 than the HCs (13.10% vs 5.05%, P = .025). The AF of HLA-A*26, -A*26:01 and -B*51:01 also was higher and almost reached statistical significance (5.59% vs 1.52%, P = .054, 5.95% vs 1.52%, P = .054 and 10.71% vs 4.04%, P = .051, respectively). However, the BD patients had significantly higher AF of either HLA-A*26:01 or -B*51:01 (16.67% vs 5.56%, P = .005), or -A*26:01 or -B*51X (19.05% vs 6.56%, P = .003). The AF of HLA-B*51:01 and -B*51X increased significantly in -A*26:01 non-carrier BD patients (12.16% vs 4.17%, P = .024 and 14.86% vs 5.21%, P = .019, respectively); and that of HLA-A*26:01 was significantly higher in -B*51X non-carrier BD patients (7.58% vs 1.67%, P = .034). HLA-B*51:01 associated significantly with the presence of posterior uveitis and visual impairment (18.18% vs 2.50%, P = .031 for both conditions). HLA-B*51:01 was not observed in BD patients with gastrointestinal involvement or arthritis. Furthermore, the AF of HLA-B*51:01 was significantly higher in HLA-A*26:01 non-carrier BD patients without arthritis (17.30% vs 0%, P = .050). CONCLUSION: HLA-B*51:01 was a susceptible allele for Thai BD patients, and associated with posterior uveitis and visual impairment. HLA-A*26:01 was another susceptible allele in HLA-B*51X non-carrier patients. The protective effect of HLA-B*51:01 on arthritis needs further investigation.
22
Fereydoun Davatchi, Samir H. Assaad‐Khalil, Kenneth Calamia et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 1.4K citations · Full text
Medicine, Internal Medicine, Clinical Classification Systems +10
Kai Cao, Jill A. Hollenbach, Xuejiang Shi et al. · Human Immunology · 2001 · 467 citations
Behçet’s disease, the Silk Road and HLA‐B51: historical and geographical perspectives
David H. Verity, Jane Marr, Shigeaki Ohno et al. · Tissue Antigens · 1999 · 453 citations
Life Sciences, Genetics, Immunology +17
Genetics of Behçet disease inside and outside the MHC
Akira Meguro, Hidetoshi Inoko, Masao Ôta et al. · Annals of the Rheumatic Diseases · 2009 · 138 citations
Life Sciences, Genetics, Immunology +17